A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV

NCT01599975 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV Dementia

Interventions

DRUG: Long acting methylphenidate
DRUG: Long acting methylphenidate
DRUG: Matched placebo

Sponsor

University of California, Los Angeles